FNF EVP granted 27,827 restricted shares; total holdings 307,404 direct

Fidelity National Financial (FNF) reported an insider equity award.

Accepted by SEC EDGAR 11/13/2025 - 04:31 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Fidelity National Financial (FNF) reported an insider equity award. On 11/10/2025, an Executive Vice President received 27,827 shares of restricted common stock at a price of $0.

The award vests in three equal annual installments beginning November 10, 2026, and is subject to performance criteria outlined in the award agreement. Following this grant, the reporting person beneficially owned 307,404.6147 shares, held directly.

Insider Trade Summary

Grant/Award: 27,827 shares

Grant/Award 1 txn

Insider Gravelle Michael L

Role Executive Vice President

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	27,827	$0.00	$0.00

Holdings After Transaction: Common Stock — 307,404.6147 shares (Direct)

Footnotes (1)

1. F1. Grant of restricted common stock vesting in three equal annual installments beginning November 10, 2026, subject to the achievement of performance criteria specified in the reporting person's award agreement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did FNF report on Form 4?

An Executive Vice President received 27,827 restricted common shares on 11/10/2025 at a price of $0.

What is the vesting schedule for the FNF restricted stock grant?

The grant vests in three equal annual installments beginning November 10, 2026, subject to performance criteria.

How many FNF shares does the reporting person own after the transaction?

After the grant, beneficial ownership is 307,404.6147 shares, held directly.

What is the relationship of the reporting person to FNF?

The reporting person is an Officer, serving as Executive Vice President.

Was there a cash purchase price for the FNF restricted shares?

No. The reported price for the restricted stock grant was $0.

Are there performance conditions tied to the FNF equity award?

Yes. Vesting is subject to performance criteria specified in the award agreement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gravelle Michael L

(Last) (First) (Middle)

601 RIVERSIDE AVENUE

(Street)

JACKSONVILLE FL 32204

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Fidelity National Financial, Inc. [ FNF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/10/2025		A		27,827(1)	A	$0	307,404.6147	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted common stock vesting in three equal annual installments beginning November 10, 2026, subject to the achievement of performance criteria specified in the reporting person's award agreement.

	/s/ Colleen E. Haley, as attorney-in-fact	11/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.